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Abstract
It is generally believed that splicing removes introns as single units from pre-mRNA transcripts. 
However, some long D. melanogaster introns contain a cryptic site, called a recursive splice site 
(RS-site), that enables a multi-step process of intron removal termed recursive splicing1,2. The 
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extent to which recursive splicing occurs in other species and its mechanistic basis remain unclear. 
Here we identify highly conserved RS-sites in genes expressed in the mammalian brain that 
encode proteins functioning in neuronal development. Moreover, the RS-sites are found in some 
of the longest introns across vertebrates. We find that vertebrate recursive splicing requires initial 
definition of a “RS-exon” that follows the RS-site. The RS-exon is then excluded from the 
dominant mRNA isoform due to competition with a reconstituted 5′ splice site formed at the RS-
site after the first splicing step. Conversely, the RS-exon is included when preceded by cryptic 
exons or promoters that are prevalent in long introns, but which fail to reconstitute an efficient 5′ 
splice site. Most RS-exons contain a premature stop codon such that their inclusion may decrease 
mRNA stability. Thus, by establishing a binary splicing switch, RS-sites demarcate different 
mRNA isoforms emerging from long genes by coupling inclusion of cryptic elements with RS-
exons.
Recursive splicing has been validated within the long introns (>24 kb) of three D. 
melanogaster genes1,2. The RS-sites in these introns contain a 3′ splice site followed by a 
sequence that reconstitutes a 5′ splice site after the first part of the intron is spliced, thereby 
allowing subsequent splicing of the second part of the intron (Fig. 1a). While one 
mammalian sequence was proposed to function as an RS-site when pre-spliced to an 
upstream exon in a splicing reporter3, recursive splicing has not been observed in 
endogenous vertebrate genes. This is despite >8000 human protein-coding genes containing 
introns >24 kb, and many vertebrate genes containing motifs similar to the D. melanogaster 
RS-sites4.
Long genes exhibit elevated expression in the nervous system, as evident by analysis of 
human tissues or differentiating cells (Fig. 1b, Extended Data Fig. 1b-d)5, and are enriched 
in GO terms associated with the nervous system (Extended Data Fig. 1a). We therefore 
produced 1.5 billion paired-end total RNA sequencing (RNA-seq) reads from four post-
mortem brains to search for new splicing events in human long genes. Importantly, RNA 
abundance decreases linearly from the 5′ to 3′ end of long introns to create “saw-tooth” 
patterns in total RNA-seq data6 and these can be used to infer locations of major splicing 
events (Fig. 1c-d, Extended Data Figs. 2a, 3). We also performed crosslinking and 
immunoprecipitation (iCLIP) of the RNA-binding protein “fused in sarcoma” (FUS) in 
human brain. FUS binds across entire pre-mRNAs with limited sequence specificity7, 
permitting an independent examination of the saw-tooth patterns (Fig. 1d, Extended Data 
Fig. 3a-g).
Cryptic splice sites can be identified from novel splice-junction reads in RNA-seq data 
(Extended Data Fig. 2c-e). We hypothesized that if some of these were major splicing 
events, they should cause significant deviations from the expected linear decrease of reads 
across long introns (Fig 1c-d). Analysis of our RNA-seq data identified 40163 unique, 
unannotated cryptic splice sites in introns >1 kb that contained either 5′ or 3′ splice site 
motifs, 419 of which conformed to the RS-site motif (Supplementary Table 1). We 
evaluated deviations from the expected saw-tooth pattern by establishing an analysis that 
computed the fit of linear regression slopes of each intron as a single unit or as two units 
separated at newly detected intra-intronic junctions (Fig. 1c-e, Extended Data Figs. 2a-b, 3). 
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Since intron size is a critical determinant of our ability to reliably detect unexpected saw-
tooth patterns, we restricted analysis to genes with at least one intron >150 kb. This 
identified 19 unique cryptic splice sites in the long introns of 14 genes that significantly 
improved the goodness-of-fit of the regression model in both RNA-seq and FUS iCLIP 
datasets. Of these, 9 had the RS-site motif whilst the remainder had a 3′ splice site motif 
(p<0.01 in both datasets, Fig. 1d-f, Supplementary Table 1). The genes containing these 9 
RS-sites mostly function in cell adhesion and axon guidance and are linked to 
neurodevelopmental disorders (Supplementary Table 2).
The 9 RS-sites occurred at transition points of intronic linear regression slopes in all four 
individuals and all brain regions profiled (Fig. 1d, Extended Data Figs. 3, 4). RT-PCR from 
a separate human brain confirmed splicing to 8 RS-sites at identical PCR cycle number as 
the mature mRNA, suggesting equal abundance, while no PCR products were observed 
when reverse primers were shifted upstream of RS-sites (Fig. 2a, Extended Data Fig. 5a-g).
Notably, an alternative 5′ splice site is present downstream of each RS-site that could lead to 
inclusion of alternative exons (hereafter “RS-exons”, Fig. 2b). However, RS-exons were not 
detectable in mRNA transcripts at comparable PCR cycle numbers used to detect RS-site 
junctions (Fig. 2a, Extended Data Fig. 5a-g), arguing that RS-sites are being used for 
recursive splicing and not RS-exon inclusion. Despite RS-exon skipping, mammalian 
conservation of both the RS-sites and alternative 5′ splice sites following the RS-exons is 
comparable to that of canonical 5′ and 3′ splice sites (Fig. 2c-d, Extended Data Fig. 5i). 
Indeed, mouse Fus iCLIP regression patterns directly match conserved RS-sites (Extended 
Data Fig. 6a-h)7.
Splicing of most vertebrate exons requires exon definition8, where both splice sites flanking 
an exon are recognized in unison via interactions between U2AF proteins, SR proteins and 
U1/U2 snRNPs9 (Supplementary Information). We speculated that RS-exons co-evolved 
with RS-sites to enable exon definition (Fig. 2e). Accordingly, we masked the 5′ splice site 
following the CADM1 and ANK3 RS-exons in SH-SY5Y neuroblastoma cells using an 
antisense oligonucleotide (AON-A1; Fig. 2e). This dramatically reduced RS-site usage in 
both genes (Fig. 2f). We subsequently replicated this observation in vivo at the conserved 
RS-site/RS-exon of the zebrafish cadm2a gene (Fig 2g, Extended Data Fig. 5h). The 
reduced RS-site usage also led to a ~6-fold increase in abundance of the intronic region 
upstream of both human RS-sites, indicating a change in the saw-tooth pattern consistent 
with splicing of intron as a whole (Fig. 2h). Interestingly, the reduced RS-site usage caused 
a ~2-fold reduction in zebrafish cadm2a total mRNA (Fig. 2i), an effect not seen for the 
human CADM1 and ANK3 genes (Fig. 2j, Supplementary Information). Despite RS-exons 
usually being skipped, our findings demonstrate that RS-exon definition is crucial for the 
initial step of vertebrate recursive splicing (Figs. 2e, 4i).
Since recursive splicing requires initial definition of an RS-exon, we questioned whether 
some annotated alternative exons might function as RS-exons. We found 99 candidate 
annotated RS-exons with RS-site sequences located precisely at their starts (Extended Data 
Fig. 7a). Splice-junction reads from brain RNA-seq data were present at the start of 16 of 
these exons despite evidence for exon skipping. These included exons in the CADM2 and 
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NTM genes that significantly improved the goodness-of-fit of linear regression in RNA-seq 
and iCLIP datasets across their >150 kb introns (Fig. 4a, Extended Data Fig. 7e, 
Supplementary Table 1). We confirmed RS-site mediated exon-skipping in both genes by 
RT-PCR (Extended Data Fig. 7b,f). Thus, the first intron in CADM2 gene contains two RS-
sites; the first followed by an unannotated RS-exon, and the second by an annotated RS-
exon.
To further validate the exon definition mechanism, we established a splicing reporter 
containing the second CADM2 RS-site, the annotated RS-exon and its 5′ splice site, and the 
surrounding constitutive exons, each flanked by their nearest ~100 nt of CADM2 intronic 
sequence (P1; Fig. 3a). Despite the >500 kb long intron being reduced to ~0.5 kb, the 
reporter replicated findings of endogenous genes; 79% of mRNA isoforms skipped the RS-
exon whilst RS-site usage was readily detected (Fig. 3b, Extended Data Fig. 8a). As 
expected given the need for exon definition to recognise RS-sites, mutating the 5′ splice site 
following the RS-exon greatly reduced RS-site usage, and the intron remained a single unit 
in most splicing intermediates (P1-m1, Fig. 3a-b, Extended Data Fig. 8a).
Next, to examine why RS-exons are excluded from the mRNA, we mutated the CADM2 
reporter’s RS-site to prevent formation of reconstituted 5′ splice site after the first splicing 
event (Fig. 1a). Strikingly, this resulted in complete inclusion of the RS-exon, implying 
competition exists between the two 5′ splice sites at either end of the RS-exon (P1-m2, Fig. 
3a-b). To compare with endogenous genes, we designed AON-A2 to mask the section of 
RS-sites that contributes to the reconstituted 5′ splice site in the human CADM1, ANK3 or 
zebrafish cadm2a genes (AON-A2, Fig. 3a). Agreeing with the splicing reporter, AON-A2 
dramatically increased RS-exon inclusion in all human and zebrafish experiments (Fig. 3c, 
Extended Data Fig. 8b). Collectively, this demonstrates that the RS-exon is skipped due to a 
splice site competition that leads to use of the reconstituted 5′ splice site instead of the 5′ 
splice site of the RS-exon (Figs. 3a, 4i, Supplementary Information).
We noticed that RS-exons typically contain one or more in-frame stop codons (Fig. 2b, 
Extended Data Fig. 5i), inclusion of which should prevent translation of full-length protein 
and target transcripts with preceding start codons to nonsense-mediated decay (NMD)10. We 
induced inclusion of the RS-exons in CADM1 and ANK3 by masking the 5′ splice site of 
their RS-sites with AON-A2, and then inhibited NMD by blocking translation with 
cycloheximide. This increased the proportion of isoforms containing the RS-exon (Fig. 3d), 
confirming that RS-exon inclusion can target transcripts for NMD and thus has potential to 
regulate transcript stability (Supplementary Information).
Having identified the mechanisms underlying vertebrate recursive splicing, we next 
explored the functions of RS-sites. Although D. melanogaster RS-sites have been proposed 
to maintain splicing integrity of long introns4, the assayed human and zebrafish long introns 
remained accurately spliced after recursive splicing inhibition with AON-A1 (Extended 
Data Fig. 8c). We therefore explored an additional hypothesis that RS-sites regulate 
inclusion of RS-exons under specific contexts. We identified minor isoforms in the CADM2 
and NTM genes that use a different promoter, and were therefore not detected by our initial 
RT-PCR reactions. Their detection required 10 more amplification cycles compared to the 
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dominant isoform, confirming that they are minor isoforms (Extended Data Figs. 7c-d, 7g). 
Surprisingly, RS-exons are completely included in these minor isoforms that have an 
alternative exon or promoter preceding the RS-site (Fig. 4a-c, Extended Data Fig. 7c-g). 
Similarly, the RS-exon is also detected in expressed sequence tags (ESTs) of minor OPCML 
isoforms that contain alternative exons preceding the RS-site (Extended Data Fig. 9a). A 
related splicing mechanism that coordinates alternative promoters with downstream 
alternative splicing was been observed in the human EPB41 and EPB41L3 genes, although 
this involves a reconstituted 3′ splice site to make it distinct from recursive splicing11.
To understand how preceding exons can dictate inclusion of RS-exons in a binary manner, 
we compared the computationally predicted strengths of the three relevant 5′ splice sites in 
CADM212; the 5′ splice sites reconstituted from the RS-site after its splicing to the preceding 
exon of either the dominant or minor isoforms, and the 5′ splice site of the RS-exon (Fig. 
4d). We used the last three nucleotides of the preceding exon and the six nucleotides from 
the RS-site to calculate the scores of the reconstituted 5′ splice sites12. We found that the 
reconstituted 5′ splice site had a high score when the first exon is derived from the dominant 
promoter (10.6), a low score when derived from the minor promoter (5.1), whilst the 5′ 
splice site of the RS-exon had an intermediate score (7.0). This indicates that strength of the 
reconstituted 5′ splice site likely dictates whether the RS-exon is included or skipped. 
Indeed, 5′ splice sites reconstituted from the preceding exon of the dominant isoform in all 9 
high-confidence RS-sites had equal or higher splice site scores than the 5′ splice sites of 
their corresponding RS-exons, in agreement with observed RS-exon skipping (Extended 
Data Fig. 8d, Supplementary Table 3).
To evaluate experimentally, we mutated the 5′ splice site of the CADM2 RS-exon in our 
splicing reporter such that its score was higher (12.2) than the reconstituted 5′ splice site of 
the dominant isoform (10.6, P1-m3, Fig. 4d). This mutation favored RS-exon inclusion (Fig. 
4e). We then replaced the preceding exon of the dominant isoform with the one from the 
minor isoform. This led to complete inclusion of the RS-exon, re-capitulating behavior of 
the endogenous gene (P2, Fig. 4d,f). Finally, swapping the last three nucleotides of the 
preceding exon in the minor isoform to the sequence of dominant isoform led to RS-exon 
skipping, consistent with the higher score of the reconstituted 5′ splice site (10.6, P2-m1, 
Fig. 4d,f). These results reveal that the binary splicing switch is a consequence of the 
relative strengths of competing 5′ splice sites present after the RS-exon is spliced to the 
preceding exon.
Introns containing the high-confidence RS-sites are amongst the longest introns in all 
vertebrate species (Fig. 4g, Extended Data Fig. 9b). This includes Tetraodon nigroviridis, 
which has the shortest known vertebrate genome and otherwise contains very short 
introns13. Further, 8/9 of our high confidence RS-sites are located in the long first intron of 
the gene. We confirmed that long introns generally have an increased incidence of cryptic 
exons and noisy splicing14,15 by observing an increased incidence of cryptic junctions in our 
RNA-seq data in long first introns (Extended Data Fig. 9c). Since the majority of the 435 
putative RS-sites identified in our study are present in the longest human genes (419 intronic 
loci, 16 annotated RS-exons, Fig. 4h), RS-sites are thus well positioned to couple inclusion 
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of cryptic exons with RS-exons. As most RS-exons contain a premature stop codon, this 
may also allow quality control of the novel mRNA isoforms (Supplementary Information).
In summary, recursive splicing of long vertebrate genes involves two steps (Fig. 4i). First 
the RS-exon is defined, which requires its own 5′ splice site. Following splicing of the RS-
exon to the preceding exon, a new 5′ splice site is reconstituted from the RS-site that 
competes with the 5′ splice site of the RS-exon. The strength of the reconstituted 5′ splice 
site determines whether the RS-exon is skipped via recursive splicing or included. Notably, 
the upstream exons of dominant isoforms reconstitute a strong 5′ splice site that leads to 
recursive splicing, whereas other alternative exons, which commonly emerge in long introns 
to produce minor isoforms, generally end in sequences that lead to RS-exon inclusion. In 
lieu of studies linking aberrant expression of long genes to neurologic diseases16-18, 
mutations or deletions around RS-sites may also contribute to human genetic diseases.
Methods
RNA-seq library preparation and sequencing
Brain samples for analysis were provided by the Medical Research Council Sudden Death 
Brain and Tissue Bank (Edinburgh, UK). Transcriptomic analysis of postmortem human 
tisue was approved by The National Hospital for Neurology and Neurosurgery & Institute of 
Neurology Joint Research Ethics Committee, UK (REC reference number 10/H0716/3). All 
four individuals sampled were of European descent, neurologically normal during life and 
confirmed to be neuropathologically normal by a consultant neuropathologist using 
histology performed on sections prepared from paraffin-embedded tissue blocks. Twelve 
central nervous system regions were sampled from each individual. The regions studied 
were: cerebellar cortex, frontal cortex, temporal cortex, occipital cortex, hippocampus, the 
inferior olivary nucleus (sub-dissected from the medulla), putamen, substantia nigra, 
thalamus, hypothalamus, intralobular white matter and cervical spinal cord.
RNA was extracted using Qiagen tissue kits (Qiagen, US), and quality controlled as detailed 
previously20. Libraries were prepared by the UK Brain Expression Consortium in 
conjunction with AROS Applied Biotechnology A/S (Aarhus, Denmark). In brief, 100 ng 
total RNA was used as input for cDNA generation using NuGen’s Ovation RNA-seq System 
V2 (NuGen Technologies, US). The RNA was processed according to the manufacturer’s 
protocol resulting in amplified cDNA from total RNA and concomitant de-selection of 
rRNA. Importantly, reverse transcription in this protocol is carried out using both oligo dT 
and random primers. This allowed total RNA profile patterns to be assessed with the latter 
and locations of splicing to be inferred. 1μg of the cDNA was fragmented using a Covaris 
S220 Ultrasonicator and the fragmented cDNA was used as the starting point for Illumina’s 
TruSeq DNA library preparation (Illumina, US). Finally, library molecules containing 
adapter molecules on both ends were amplified through 10 cycles of PCR. The libraries 
were sequenced using Illumina’s TruSeq V3 chemistry / HiSeq2000 and 100 base pair 
paired-end reads. The sequencing data was converted to fastq-files using Illumina’s 
CASAVA Software.
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RNA-seq processing
Paired end RNA-seq data was mapped to the human genome (hg19) using STAR aligner (v 
2.3) with default settings and known splice junctions from GENCODE21,22. For high-
confidence RS-site junction detection, alignments were processed from all intronic regions 
>150 kb using an in-house processing pipeline implementing python (v2.7.2), Bedtools 
(v2.17.0) and R (v 3.0.0). This size limit was chosen since linear regression patterns could 
most readily be evaluated in such long introns (Extended Data Fig. 2a-b), and represented 
943 introns in 780 genes (RefSeq release 60). Alignments from all 48 samples in >150 kb 
introns were combined and processed together unless indicated in the text. All spliced 
alignments with minimum flanking overhang of >10 nt (hereafter: “anchor”) and junction 
region exceeding 5 kb were selected and considered for further analysis. Each anchor 
sequence was then annotated to verify it conformed to a known splicing boundary (hereafter: 
exon anchor). All further analysis was done using only those novel junctions that had a 
single exon anchor (Extended Data Fig. 2c). Novel junctions were then ruled out if they 
were not detected across either multiple brain regions or in multiple patients. We 
subsequently asked whether intronic sequences immediately adjacent to the novel junctions 
contained pentamers found at 1% of all 5′ splice sites genome-wide (Extended Data Fig. 2d), 
or sequences located at 3′ splice sites (polypyrimidine tract consisting of >11 pyrimidines 
present in the region of −22 to −1, including YAG as last three positions; Extended Data 
Fig. 2e). Novel junctions within 418nt nucleotides of one another, the 95th percentile of 
exon lengths genome-wide, were considered in close enough proximity to have potential for 
exon formation. This analysis identified 2981 novel junctions in introns >150 kb; 979 joined 
an upstream exon to an intronic 3′ consensus splice site, 1296 joined an intronic 5′ 
consensus splice site with a downstream exon, and 353 pairs of junctions were proximally 
spaced in a manner that could form a novel exon (Supplementary Table 1 (Worksheet 1)). 
For low confidence RS-site junction detection in introns >1 kb, the same process was 
repeated in which alignments were now processed from all intronic regions >1 kb, and the 
minimum novel junction span was now 100 bp. RS-sites identified in this analysis were not 
tested with linear regression analysis due to shorter intron lengths having less reliable 
intronic read density profiles. In total 65173 un-annotated novel junctions were detected, 
43229 of which joined intronic elements with consensus motifs of either 3′ or 5′ splice sites 
(Supplementary Table 1 (Worksheet 2)). Of these, 40163 were unique loci and 419 of them 
contained RS-site motifs. From these 419 unique and putative RS-sites, 48 were present in 
long gene introns.
iCLIP library preparation, sequencing and processing
FUS iCLIP experiments were performed as previously described23 with minor 
modifications. FUS iCLIP was performed with NB100-565 antibody (Novus Biologicals, 
US) at a concentration of 5 μg/mg on human brains, whilst FUS iCLIP from mouse brain 
was obtained from the previous study7. Sequencing was performed on either an Illumina 
GA-II or Illumina Miseq. The iCLIP libraries contained a 4-nt experimental barcode plus a 
5-nt random barcode, which allowed multiplexing and the removal of PCR duplicates, 
respectively. The iCLIP data were mapped to hg19 using Bowtie24 and further processed as 
described previously23.
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Computational analyses
All scripts used for the analyses in this paper are available at the Github repository (https://
github.com/vplagnol/recursive_splicing).
Linear regression analysis
To establish the analysis of linear regression, each annotated intron greater than 50kb (in at 
least one Ensembl transcript) was first analyzed independently (Extended Data Fig. 2a-b). 
Following evaluation of different sized windows, we ultimately divided introns in to 5 kb 
bins. For both the RNA-seq and FUS iCLIP data, we then computed the number of read 
pairs mapping to each bin using samtools v0.19. We then ran a regression analysis with the 
number of mapped reads in each bin as a dependent variable. As a test, we first used this to 
examine genes containing multiple introns >50 kb. This showed that slopes of fitted 
regression lines were comparable for different long introns of the same gene (Extended Data 
Fig. 2a-b). Since the slope depends on transcriptional elongation rate, this observation agrees 
with the finding that transcription rate is relatively constant across individual genes25. We 
therefore assumed a constant (unconstrained) slope across each entire gene. Reducing the 5 
kb bin size or the intron length cut-off reduced the reliability in the method, implying 
individual units of >50 kb are most appropriate for this computational analysis. Accordingly, 
when splitting introns into two separate parts based on novel junctions, we focused on >150 
kb introns to adequately account for this size limit.
Next, for our baseline model, we coded the positions of all potential exons located in the 
>150 kb intron long gene introns (based on Ensembl annotations) using binary dummy 
variables and let the fitted read count data reset to an arbitrary value at each putative exon. 
We then considered for each intron a set of augmented models that include the same 
covariates at the baseline model (constant slope, dummy variable for potential exons) in 
addition to an additional dummy variable for each of the novel junctions identified by the 
split read analysis. We used a standard F test P-value to compare the fit between the baseline 
model and the augmented one in order to quantify the improvement of the goodness-of-fit 
provided by each additional potential RS-sites. Introns were eventually ranked on the basis 
of these F test P-values, with significance threshold for further analysis set at p<0.01 for 
both datasets (Supplementary Table 1 (Worksheet 3)). Taken together, the following 
filtering workflow was used in linear regression analysis for production of Fig. 1d:
1 Select novel junctions, which connect upstream exon to deep intronic loci.
Initial Junctions - 1378
2 Exclude junctions where gradient remains negative after strand correction.
Remaining - 1146
3 Selected lowest p-value for a junction if multiple introns overlap. Removed 
higher p-values since RNAseq has depth to identify most frequently used 
introns.
Remaining - 536
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4 Plot after/before ratios. After/before ratios >1 correspond to increased slope, and 
<1 to reduced slope of linear regression line across intron.
5 Significance threshold set at p<0.01 for both FUS and RNA-seq.
Remaining 24 junctions
6 Select junctions with after/before ratio of >1 in both datasets.
Remaining 21 junctions - Indicated by YES in column AF of Supplementary 
Table 1 (Worksheet 3).
Alternative GURAG exon analysis
All alternative exons within the UCSC Alt events track were evaluated for GURAG 
pentamers at their start. Two lines of evidence were then pursued to evaluate their use as 
RS-exons. First, we asked if exons overlapped intronic read transition points despite being 
skipped. Linear regression analysis was performed on all alternative exons from UCSC Alt 
Events table which fell within an Ensembl transcript and would have flanking introns both 
>50 kb (Supplementary Table 1 (Worksheet 4)). Analysis was performed using both RNA-
seq and FUS datasets. Identified GURAG exons were matched to these results to determine 
candidate exons which show high levels of inclusion. These were subsequently followed up 
through evaluation of junction counts between these exons and both upstream and 
downstream exons within RNA-seq data, and additionally junctions between the upstream 
and downstream exons in which the GURAG exon would be skipped. Limited evidence for 
recursive splicing was considered a double-significance in linear regression analysis, but 
junction counts indicating that the skipped product dominates.
Second, we asked whether these GURAG exons made regular contact with upstream exons 
with which they are not expected to junction (based on known gene isoforms). This could 
imply that the junction is used, but the GURAG exon is not included, leading to absence of 
isoform annotation. To identify known or novel junctions between the 99 GURAG 
alternative exons and upstream exons, we evaluated all junctions in RNA-seq data that were 
made between the identified 99 cassette exons and any annotated upstream exon 
(Supplementary Table 1 (Worksheet 5)). Each junction was then enumerated and classified 
as “known” or “novel” using the knowngene UCSC annotations. If a junction was not 
present in this annotation database and subsequently classed as novel, then this was 
considered limited evidence for recursive splicing. Examples were subsequently considered 
high confidence if splicing patterns inferred from the aforementioned analysis of total RNA-
seq read density patterns suggested frequent use of the novel junction. Combined, these 
analyses identified 16 putative annotated RS-exons, two of which (in the CADM2 and NTM 
genes) we further experimentally validate.
Cryptic element analysis
In order to perform this analysis while limiting duplication of the same exon due to multiple 
transcripts, RefSeq annotations were refined to include only those transcripts defined as 
canonical by UCSC knowngene table. Intersection of both annotation databases identified 
21531 second exons common to both databases. Of these, 798 were subsequently removed 
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due to a lack of evidence of gene expression across all brain regions based on gene-derived 
RNA-seq FPKM values. For the remaining 20733 second exons, upstream intronic regions 
were searched for all junctions connecting these exons to any upstream elements 
(Supplementary Table 3 (Worksheet 1)). Junctions were classified according to the nature of 
the upstream elements. Specifically we separated into three categories; “exon-exon” 
represented junctions between the canonical first exon and second exon, “isoform” 
represented junctions between an alternative first exon and the second exon that are present 
in UCSC/RefSeq/GENCODE databases, and “novel” represented entirely unexpected 
junctions between intronic elements in the UCSC/RefSeq/GENCODE databases that 
junction to the second exon. We restricted our final analysis of cryptic upstream elements to 
the 6619 genes in which a canonical exon-exon junction was detected which accordingly 
span the full-length of the canonical first intron. The number of novel junctions to cryptic 
upstream elements were then counted in these genes, with genes grouped in bins based on 
the length of the canonical first intron. To avoid overlap with non-canonical minor 
transcripts, “isoform” junctions were not considered. Significance between bins was 
determined using the Mann-Whitney U test with two tails.
To evaluate cryptic element usage to all 142 candidate RS-sites (high confidence targets, all 
cassette exons starting with GURAG, and novel junctions detected that were consistent with 
RS-sites but failed to meet significance in linear regression analysis), the upstream gene 
body of candidate RS-sites genes were searched for all junctions present within brain RNA-
seq libraries that connected these candidate RS-sites to any upstream elements 
(Supplementary Table 3 (Worksheet 2)). Junctions were then classified according to the 
nature of the upstream elements. Specifically we asked whether the junction was to an 
annotated upstream exon or cryptic exon/promoter.
Gene expression comparisons
For tissue-specific gene expression comparisons in Extended Data Fig. 1, RNA-seq data 
from 16 human tissues obtained by the Illumina Human Body Map Project (GEO series 
accession number GSE30611) and RNA-seq data from 12 human tissues collected as part of 
the Genotype Tissue Expression (GTEX) Project (http://www.gtexportal.org) were mapped 
to hg19 genome with TopHat226. For the cell line comparisons mapped in the same way to 
either hg19 or mm9, data was collected from the following sources: myoblast differentiation 
(mm9, GEO series accession number GSE20846), erythropoiesis (hg19, GEO series 
accession number GSE40243), motor neuron differentiation (mm9, GEO series accession 
number GSM1346027). Mean expression values across replicates was calculated using 
DESeq19. Tissue-specific comparisons were made between the brain and all other individual 
tissues for all protein coding genes. For cell-specific comparisons, differentiated cells were 
compared to un-differentiated cells in respective datasets. Log2-fold expression changes 
were plotted as a function of gene length. In incidences where multiple gene lengths were 
reported for a given gene, the maximum gene length was used.
Cross species intron lengths
To determine cross-species intron lengths, all human RefSeq genes were mapped to 
indicated species using the xenoRefGene track. Corresponding intron lengths were 
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determined using exon start and exons end coordinates from all single-mapping transcripts. 
Identical introns found across multiple transcripts of the same gene were collapsed into a 
single unique intron for analysis so not to be counted multiple times.
GO term analysis
The GO term associated with >150 kb human UCSC genes analyzed by Gorilla27 using two 
unranked lists of genes. UCSC genes >150 kb were used as targets, while all UCSC genes 
were used as background. For visualization, GO terms with > 1E−3 FDR q-value or less than 
2-fold enrichment were omitted.
Motif analysis
Sequence analysis around novel junction intronic loci was performed using WebLogo28. 
Recursive exon maps were generated by string matching consensus 5′ splice sites and stop 
codons to regions following RS-sites after considering open reading frame of upstream 
RefSeq exons. Strong consensus splice sites were considered GTAAG, GTGAG, GTAGG, 
GTATG (Fig. 2b, Extended Data Fig. 5i). Weak consensus splice sites are GTAAA, 
GTAAT, GTGGG, GTAAC, GTCAG, GTACG (Extended Data Fig. 5i).
Splice site score calculation
MaxEntScan was used as previously described using the First-order Markov Model setting 
by adding the last three nucleotides of the exon and the first 6 nucleotides of the 5′ splice 
site12. Competing splice site scores are presented in Supplementary Table 3 (Worksheet 3) 
and Extended Data Fig. 8d.
Conservation scores
For conservation scores, the 46-way placental mammal conservation by PhastCons track on 
the UCSC genome browser was used (phastCons46wayPlacental). Conservation scores were 
obtained for a given region using table browser, and mean scores calculated after alignment 
to specified features. Conservation was calculated at RS-sites (n=9), at 5′ splice sites 
downstream of RS-exons (n=9), at 5′ and 3′ splice sites flanking constitutive exons in genes 
containing RS-sites (n=130), and at the next two nearest 5′ splice sites downstream of RS-
exons (n=18).
Cell culture
SH-SY5Y cells (ATTC, CRL-2266) were cultured at 37°C, 5% CO2 in Dulbecco’s Modified 
Essential Medium (Life technologies, US) supplemented with 10% Fetal Bovine Serum. For 
all treatments in this cell line, cells were seeded to be 70-80% confluent at the day of 
transfection in 6-well plates.
For antisense oligonucleotide (AON) treatment, cells were transfected at 24 hr with 10 μM 
of stated AON using Endo-porter transfection reagent (Gene-tools, US) as per manufacturers 
instructions. At 48 hr post-transfection cell media was removed and cells lysed and RNA 
extracted with Qiazol. All AONs were purchased from Gene-tools, US, and carried 
morpholino modifications. Sequences used were:
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CADM1:
AON NS: CCTCTTACCTCAGTTACAATTTATA
AON-A1: AGCACACATGAGAAGTATGACTTAC
AON-A2: ATCCAAGCATAAGATTGTCACTTAC
ANK3:
AON NS: CCTCTTACCTCAGTTACAATTTATA
AON-A1: TTTAAAATGGAAAACCAGCACTTAC
AON-A2: AATGGCCAATGCCAAGTTCACTTAC
For cycloheximide treatment after AON-A2 transfection, cells were seeded to be 50-70% 
confluent at the day of transfection and were treated at 48 hr (first experiment) or 36 hr 
(second experiment) with either 100 μg/ml of cycloheximide dissolved in DMSO, or an 
equivalent volume of DMSO alone. At 6 hr post-treatment cell media was removed and cells 
lysed and RNA extracted using Qiazol (Qiagen, US).
Zebrafish AON treatments
Zebrafish experiments were performed by injecting 1 ng of AON (Gene-tools, US)into the 
yolk of 1 cell-stage embryos. Embryos were grown at 28.5 °C and were collected at 2 days 
post-fertilisation for RNA extraction.
AON NS: CCTCTTACCTCAGTTACAATTTATA
AON-A1: GTGGAAAAAAATACCCAAGACTCAC
AON-A2: AATGCTTCATTCAGTCTGTACTCAC
Splicing reporter design
The CADM2 splicing reporter mini-gene (P1) was designed such that the RS-exon following 
the second CADM2 RS-site was flanked by two short introns and the surrounding CADM2 
constitutive exons (Supplementary Table 4). Introns consisted of the first ~100nt and last 
~100nt of respective introns separated by multiple cloning sites. Constitutive exons were 
flanked by HindIII and EcoRI sites respectively. Constructs were sub-cloned into the 
pcDNA3 multiple cloning site of the pBluescript plasmid using HindIII and EcoRI sites. 
Construct P2 was subsequently generated by removing the dominant first CADM2 exon and 
first ~100 nt of intron present in construct P1 with HindIII and FseI, and subcloning a 
separate synthetic gene product into the digested plasmid. This synthetic gene product 
consisted of the alternative first exon and first ~100 nt of the corresponding intron. 
Sequences of synthetic gene products can be found in Supplementary Table 4. Mutations to 
both mini-gene variants were made by cross-over PCR using construct P1 or P2 as targets 
and primers listed in Supplementary Table 4.
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Cell fractionation
For nuclear-cytoplasmic fractionation of cell lines, samples were suspended in 1 ml 
cytoplasmic lysis buffer (50 mM Tris-HCl pH 7.4, 10 mM NaCl, 0.5% NP-40, 0.25% Triton 
X-100, 1 mM EDTA, 1/200 volume of RNAsin and 1/100 vol of protease inhibitor cocktail) 
and homogenized by pipetting. Sample was spun for 3 min at 3000xg. Supernatant was 
collected as the cytoplasmic fraction and subjected to a further spin at 10000xg for 10 min. 
Supernatant was removed and RNA extracted using Trizol LS (Life technologies, US) and 
the Zymogen RNAdirect extraction kit (Zymogen, US) as per manufacturers instructions. 
The pellet from the initial spin was retained as the nuclear fraction and lysed using Qiazol 
before RNA was extracted using the Zymogen RNAdirect extraction kit (Zymogen, US) as 
per manufacturer’s instructions.
RNA extraction
For cell culture experiments Qiazol (Qiagen, US) suspended RNA was extracted using the 
Zymogen RNAdirect extraction kit (Zymogen, US) as per manufacturer’s instructions. For 
brain total RNA extraction and zebrafish tissue total RNA extraction, tissue was first 
suspended in Qiazol (Qiagen, US) and homogenized using a TissueRuptor (Qiagen, US). 
RNA was then extracted using the Zymogen RNAdirect extraction kit (Zymogen, US) as per 
manufacturer’s instructions.
RT-PCR analysis
All RNA was reverse transcribed using the high capacity cDNA synthesis kit (Applied 
Biosystems, US) using random primers and standard protocol. A total of 1μg was used in 
each reaction and cDNA then diluted according to downstream application. For RT-PCR 
samples were diluted 1:5 and 1 μl used for each subsequent PCR reaction. For qPCR 
samples were diluted 1:10 and 5 μl used for each subsequent PCR reaction.
For RT-PCR analysis, 10 ng cDNA was amplified using 2X Phusion PCR mastermix 
(Thermo-scientific) as per manufacturer’s instructions and each primer at a final 
concentration of 0.5 μM. Products were run on pre-cast 6% TBE gels (Life Technologies, 
UK) using low molecular weight marker (New England Biolabs, US) or Hyperladder V 
(Bioline, UK) as a ladder. Where exon inclusion was determined from RT-PCR images, 
band intensity of expected product sizes were determined using ImageJ software and 
expressed as a percentage of total intensity for all expected bands with indicated primers.
For Qiaxcel analysis cDNA was amplified with 2X Phusion PCR mastermix (Thermo-
scientific) as per manufacturer’s instructions and each primer at a final concentration of 0.5 
μM. Samples were subsequently purified using QIAquick PCR Purification Kit and loaded 
onto a Qiaxcel DNA cartridge (Qiagen, US) and run next to a 50-800 bp DNA marker 
(Qiagen, US) on the Qiaxcel machine (Qiagen, US) as per manufacturer’s instructions.
For qPCR analysis, 25 ng of cDNA was amplified using SYBR green PCR mastermix 
(Applied Biosystems, US) and each primer at a final concentration of 0.165 μM. PCR was 
carried out using an Applied Biosystems 7900HT machine (Applied Biosystems, US) as per 
manufacturer’s instructions and quantification assessed according to standard curves 
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generated for each primer. Signal for each interrogated junction in qPCR analysis of human 
genes is normalized to GAPDH and/or EIF4A2 gene expression, and in zebrafish to β-actin1 
and eif4a gene expression.
Primer sequences used for RT-PCR analysis and expected product sizes can be found in 
Supplementary Table 4.
Extended Data
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Extended Data Fig. 1. Long gene expression is enriched in the brain
a) GO term analysis of genes >150 kb relative to all human genes. All GO terms are 
associated with enrichment scores >2. b) Log2-fold gene expression ratios following 
differential expression sequencing (DESeq)19 analysis of all human protein-coding genes 
between the brain and all other tissues. Data are represented as Loess smoothing curves after 
the genes by their maximum length in kb. Hashed vertical line indicates 150 kb gene length. 
RNA-seq data was obtained from the GTEX consortium. c) Individual scatterplots used to 
create panel (Fig. 1b) and representing differential expression sequencing (DESeq)19 
analysis of individual genes within indicated tissues compared to the brain. Red dots 
indicate genes that contain RS-sites, blue dots indicate dystrophin and black dots indicate 
titin (two long genes most highly expressed in muscle tissues). Grey dots are all remaining 
genes. d) Differential expression sequencing (DESeq)19 analysis of individual gene 
expression after and before differentiation of C2C12 mouse myoblasts (GSM521256) into 
myogenic lineage (GSM521259)29, after or before differentiation of mouse embryonic stem 
cells (GSM1346027) into motor neurons (GSM1346035)30, or after or before differentiation 
of hematopoietic stem cells (GSM992931) into erythroid lineage (GSM992934)31. Loess 
smoothing curves are shown after sorting the genes by their maximum length in kb. Hashed 
vertical line indicates 150 kb gene length.
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Extended Data Fig. 2. Linear regression analysis and novel junction sequence considerations 
used to identify mammalian recursive splice sites
a) Examples of RNA-seq read density patterns for three genes together with their calculated 
gradients across the (i) first intron >50 kb and (ii) the average across all other >50 kb long 
introns within the same gene. Gradients represent the change in summated read count every 
5 kb since RNA-seq reads are grouped in 5 kb windows and linear regression performed on 
resulting histograms. b) Density plot indicating the ratio of gradients of all other >50 kb 
introns within the same gene: the gradient of the first intron >50 kb. Blue hashed line 
represents ratio of 1. This would indicate that gradients for long introns within the same 
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gene are comparable and transcription is proceeding at a largely constant rate. c) Schematic 
of the bioinformatics pipeline used to identify novel junctions. d) Ranking of human 5′ 
splice site pentamer usage genome-wide. e) Nucleotide usage frequency at human 3′ splice 
sites genome-wide, and branch-point positioning relative to 3′ splice site genome-wide.
Extended Data Fig. 3. Inferred splicing patterns identify recursive splice sites within mammalian 
>150 kb intron genes
RNA-seq (red) read density patterns and normalized FUS iCLIP (green) cross-link density 
patterns for the a) OPCML b) ROBO2 c) HS6ST3 d) ANK3 e) CADM2 f) NCAM1 g) 
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PDE4D genes within human brains. RNA-seq reads and normalized FUS iCLIP cross-links 
are grouped in 5 kb windows. RefSeq introns >150 kb were searched for novel junctions and 
linear regression performed on all Ensembl introns >50 kb in which novel junctions were 
located. Gene isoforms displayed are those including introns within which significant 
junctions were identified. Red novel junctions represent significant improvements in 
goodness-of-fit in both RNA-seq and FUS regression analysis (p<0.01 in both datasets, F-
test). Blue novel junctions contact RS-exons. Grey novel junctions weren’t deemed 
significant following regression analysis. Zoomed area represents sequence at deep intronic 
loci surrounding novel junction. Phylo-P conservation track indicates sequence conservation 
across 46 levels of mammalian evolution.
Extended Data Fig. 4. Inferred recursive splicing patterns in the OPCML gene across four 
separate brains
a) RNA-seq read density patterns for the OPCML gene across 12 different regions of four 
separate brains. Gene isoform displayed is that which included the long first intron within 
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which a significant novel junction was identified. RNA-seq reads are grouped in 5 kb 
windows. Dotted arrows indicate location of experimentally derived RS-site.
Extended Data Fig. 5. RT-PCR confirmation of RS-sites in human and zebrafish samples, and 
prediction of mouse RS-exons
a) Schematic of primer design used for RT-PCR validation of novel junctions. b-g) RT-PCR 
analysis of b) CADM2 c) HS6ST3 d) ROBO2 e) PDE4D_1_1 f) PDE4D_1_2 g) 
PDE4D_2_2 genes around RS-sites using indicated primers. For PDE4D sites, first number 
after gene name indicates RS-site studied, second number indicates the upstream exon used. 
See Extended Data Fig. 3g for junctions detected. h) RT-PCR analysis of cadm2a RS-site 
junction in adult male and female zebrafish embryos, together with an alignment of 
zebrafish (ZF) cadm2a RS-site to human (HS) CADM2 RS-site. i) Map of consensus splice 
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site location and in-frame termination codons following RS-sites in indicated human genes. 
Strong consensus splice sites are GTAAG, GTGAG, GTAGG, GTATG. Weak consensus 
splice sites are GTAAA, GTAAT, GTGGG, GTAAC, GTCAG, GTACG.
Extended Data Fig. 6. Conservation of inferred recursive splicing patterns in the mouse brain
Normalized FUS iCLIP read density patterns for the a) Opcml b) Robo2 c) Hs6st3 d) Ank3 
e) Cadm1, f) Ncam1 g) Cadm2 h) Pde4d genes within the mouse brain. Normalized FUS 
iCLIP cross-link sites are grouped in 5 kb windows, and the displayed linear regression lines 
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were computed on resulting histograms. Zoomed area at deep intronic loci represents RS-
site sequences conserved from humans to mouse.
Extended Data Fig. 7. Promoter-dependent inclusion of RS-exons in CADM2 and NTM genes
a) Number of cassette and constitutive exons starting with motif GURAG. b-d) RT-PCR of 
CADM2 gene in the frontal cortex using primers indicated in (b) or Fig. 4a. RT-PCR was 
carried out on one (b) or four (c-d) human brains. In (c), the inclusion of the second RS-
exon occurs together with the minor promoter. Two bands are present for both PCR 
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reactions due to the presence of an alternatively spliced exon following the RS-exon. This 
can result in two distinct long or short isoforms. In (d), the inclusion of the 2nd RS-exon 
occurs when the 1st RS-exon is included. Schematics in (c-d) represent examined splicing 
products together with expected length of products. e) RNA-seq read density patterns for the 
NTM gene and expected human isoforms. RNA-seq reads are grouped in 5 kb windows and 
linear regression performed on resulting histograms. A cryptic minor promoter/exon 
detected by RNA-seq is indicated by vertical red line. The annotated RS-exon is indicated 
by the vertical blue line. Zoomed area represents RS-site sequence at start of the annotated 
RS-exon. Primers to assess the major and minor promoter products associated with the RS-
exon are indicated by coloured arrows. f) RT-PCR of NTM gene around RS-exon using 
indicated primers. g) RT-PCR analysis of NTM products in which the upstream exon is 
either derived from the major upstream promoter or the cryptic upstream promoter/exon. 
RT-PCR was performed in the frontal cortex of three human brains using primer sets 
indicated by coloured arrows in (e). Schematics represent possible splicing products together 
with expected length of products. Upper panel assess RS-exon inclusion, lower panel 
assesses RS-site junction detection.
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Extended Data Fig. 8. Recursive splicing regulates the alternative splicing of RS-exons
a) Qiaxcel analysis and quantification of the splicing intermediates of indicated CADM2 
splicing reporter products following transfection in SH-SY5Y cells. Primers used are 
indicated by red arrows in schematic, together with expected products and their sizes. b) 
RT-PCR analysis of the zebrafish cadm2a mRNA following in vivo injection of AON-2. 
Sequencing reveals RS-exon inclusion results in subsequent splicing to additional 
downstream cryptic elements before the second exon, explaining why RS-exon included 
product size is larger than expected. c) qRT-PCR analysis of exon-exon junctions 
surrounding the RS-site containing introns following AON-A1 mediated inhibition of RS-
site use of the human CADM1 and ANK3 genes (n=3, 1 experiment) or the zebrafish cadm2a 
gene (n=7, 3 separate experiments). d) Splice site scores of reconstituted 5′ splice sites 
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following first step of recursive splicing vs. the 5′ splice sites of corresponding recursive 
exons.
Extended Data Fig. 9. Cryptic elements are frequent in long first introns
a) UCSC annotated isoforms of the OPCML gene together with spliced ESTs detected 
across the OPCML locus. Recursive exon is marked in blue, and the preceding exons 
produced by minor promoter or cryptic splicing of the long first intron are marked in red. b) 
Lengths of the 9 introns containing the high-confidence RS-sites compared to other introns 
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across vertebrates. Results are an extension of Fig. 4g. c) Boxplot showing the detected 
number of un-annotated alternative start exons which junction to the dominant second exon 
of brain expressed genes. Only novel junctions which do not match UCSC/GENCODE 
transcripts are considered for analysis. Genes are separated into bins based on the first intron 
length of the canonical isoform. Boxplot presents median, first and third quartile boundaries 
for each bin. Additional red diamonds indicate mean values for each bin. * represents 
significance in Mann-Whitney U tests, with significance set at p<10−10. Only tests between 
the 100 kb+ bin to other bins are displayed. Right panel shows cartoon of the implications of 
boxplot results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Detection of recursive splice sites within long genes expressed in the human brain
a) Schematic of the D. melanogaster recursive splicing mechanism. b) Log2-fold gene 
expression ratios following differential expression sequencing (DESeq)19 analysis of all 
human protein-coding genes between the brain and all other tissues. Data are represented as 
Loess smoothing curves after defining genes by their maximum length in kb. Hashed 
vertical line indicates 150 kb. RNA-seq data was obtained from the llumina Human Body 
Map 2.0 total RNA-seq library (GEO accession: GSE30611). c) Schematic of the theoretical 
RNA abundance across long introns demonstrating linear regression analysis performed on 
introns before/after novel junction consideration. d) All novel junctions identified within 
CADM1 by RNA-seq data are shown on top of experimentally derived RNA-seq (red) and 
FUS iCLIP (green) read densities, both grouped in 5 kb windows. The displayed linear 
regression line was determined after the intron was split at the red novel junction. This split 
significantly improved the regression in both RNA-seq and FUS iCLIP (p<0.01 in both, F-
test). Blue novel junction contacts the RS-exon. Phylo-P sequence conservation scores are 
shown around the CADM1 RS-site across 46 mammalian species. e) Ratio of after:before 
gradients at long gene novel junctions in RNA-seq (x-axis) and FUS iCLIP (y-axis) datasets. 
Black and red dots represent junctions that significantly improve the regression gradient and 
goodness-of-fit, whereas grey dots show no improvement. Black dots are junctions 
contacting the sequence of 3′ splice sites, whereas red dots contact the sequence of RS-sites. 
Hashed lines mark upper and lower quartile ratios for each dataset. f) WebLogo of RS-sites 
identified by red junctions from panel (e).
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Fig. 2. Recursive splicing requires initial definition of RS-exons
a) RT-PCR validation of recursive splicing in ANK3 and CADM1 genes. b) Consensus 
splice site location and in-frame termination codons at RS-exons in indicated human genes. 
c-d) PhyloP conservation scores aligned at (c) RS-sites and (d) 5′ splice site of RS-exons. 
Conservation at the two nearest cryptic 5′ splice sites following RS-exons (“Nearest 5′ splice 
site”) and the canonical 5′ and 3′ splice sites in the same genes are also displayed. e) 
Schematic of the exon definition model and AON-A1 design strategy. f-g) qRT-PCR 
analysis of RS-site junctions in (f) human CADM1 and ANK3 genes (n=4 for NS, n=5 for 
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AON-A1, 2 separate experiments) or (g) zebrafish cadm2a gene following treatment with 
AON-A1 (n=7, 3 separate experiments). h) qRT-PCR analysis of intronic RNA upstream of 
RS-sites (up. intron) in CADM1 and ANK3 genes following treatment with AON-A1. 
Location of primer pair is indicated by red arrow in schematic, and expected changes in 
intronic abundance indicated by grey triangles (n=4 for NS, n=5 for AON-A1, 2 separate 
experiments). i) qRT-PCR analysis of zebrafish cadm2a mRNA using two separate primer 
sets targeting constitutive exons following in vivo injection of AON-A1 (n=7, 3 separate 
experiments). j) qRT-PCR analysis of human CADM1 and ANK3 mRNAs following 48 hr 
treatment with AON-A1. mRNA for both genes was assessed in nuclear fractions (n=4 for 
NS, n=5 for AON-A1, 2 separate experiments). For relevant panels, * represents p<0.05 
determined by two-tailed student t-test and values are mean ± S.D. Unless indicated 
otherwise, primers are indicated by coloured arrows within schematics. Replicate data are 
shown in Source Data Fig. 2.
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Fig 3. The reconstituted 5′ splice site is required for RS-exon skipping
a) Schematic of splice site competition model, the CADM2 splicing reporter P1 variants, and 
AON-A2 design strategy. b-c) Qiaxcel analysis of (b) indicated CADM2 splicing reporter 
products following transfection in SH-SY5Y cells (n=3-5, 2 separate experiments), or (c) 
human CADM1 and ANK3 genes following 48hrs treatment with AON-A2 (n=4 for 
CADM1, n=5 for ANK3, 2 separate experiments). d) Quantification of CADM1 and ANK3 
RS-exon inclusion following treatment with AON-A2 then DMSO or cycloheximide in SH-
SY5Y cells (n=4, 2 separate experiments). For relevant panels, * represents p<0.05 
determined by two-tailed student t-test and values are mean ± S.D. Primers used are 
indicated by red arrows in schematics. Replicate data are shown in Source Data Fig. 3.
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Fig. 4. Splice site competition allows a binary splicing switch for RS-exons
a) RNA-seq read density patterns in the CADM2 gene shown in 5 kb windows, with linear 
regression performed after the first intron is split at the two RS-sites indicated with blue 
vertical lines. Isoforms expressed from the dominant and minor promoters in human frontal 
cortex tissue are shown, and primer locations used for (b) indicated by coloured arrows. 
Grey forward primer is located in the first exon of dominant isoform, blue forward primer is 
located in the first RS-exon (1st RS-exon), red forward primer is located in the first exon of 
alternative isoform (P2). Zoomed area represents the sequence at the start of the second RS-
exon. b-c) RT-PCR analysis of RS-exon inclusion in (b) indicated CADM2 isoforms or (c) 
indicated NTM isoforms (n=4 and n=3 respectively, Extended Data Fig. 7). Values are mean 
± S.D. d) Schematic of CADM2 splicing reporter variants P1 and P1-m3, based on the 
dominant CADM2 isoform (white), and P2 and P2-m1, based on the minor CADM2 isoform 
(red). Splice site scores for reconstituted and RS-exon 5′ splice sites are indicated. e-f) 
Qiaxcel analysis of indicated CADM2 splicing reporter products following transfection in 
SH-SY5Y cells (n=3 or n=4, 2 separate experiments). The expected size of PCR products is 
shown next to each electropherogram. g) Lengths of the 9 introns containing high-
confidence RS-sites compared to other vertebrate introns. h) Histogram of human gene 
lengths plotted alongside the percentage of genes with RS-site-containing novel junctions. i) 
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Schematic representation of the mechanism of recursive splicing and the binary splicing 
switch as described in main text. For relevant panels, replicate data are shown in Source 
Data Fig. 4.
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